Counterfeit drugs are getting to be an increasing public and financial concern for authorities around the globe. The FDA considers that this sector has spanned the 75 billion dollar mark and accounts for more than 10 percent of the worldwide pharmaceutical sector.
Moreover, the International Narcotics Control Board approximates that over 15 percent of those drugs which are being sold across the world are fake. You can know more about the FDA drug label approval process online through https://wizmed.com/drug From the view of developing nations, this figure goes as large as 50 percent.
Image Source: Google
The Demand for Drug-Anti Counterfeiting Systems
While counterfeiting of drugs is a struggle on a worldwide level, inadequate awareness, and the very low price of fabricating lead to a greater prevalence, in developing countries.
The essential difference in this business in developed and developing nations is that in the former, counterfeit medication typically consists of life-saving medications in the kind of anti-malarial, antibiotics, and pain killers. Afterward, developed countries have been prey to fake lifestyle medications like anti-obesity and baldness prevention medication.
Adding with Tech to Combat Drug Counterfeiting
The struggle against fake drugs needs more than just one preventative technique. The concept is to move beyond only convicting counterfeiters and seizing fake medications. And dissect the whole distribution chain of pharmaceutical production to leave minimal space for mistakes.
Drug production firms around the globe are now employing merchandise-based monitoring tools to distinguish real products from their fake counterparts. Tools like tamper-evident medical and Radio Frequency Identification Systems are usually used to fight the counterfeit medication marketplace.
The constant development in fake detection technology plays an innovative role in controlling the fake drug marketplace. This together with the growth of globally co-ordinated legislation and laws in drug trade and manufacturing and certainly benefit the pharmaceutical business overall.